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Objective: Subclinical hypothyroidism and isolated hypothyroxinaemia in pregnancy have been associated with an increased risk of gestational diabetes. We aimed to ascertain if these women have a worse metabolic phenotype than euthyroid pregnant women. 
Design, Subjects and Methods: We recruited 956 healthy Caucasian women with singleton, non-diabetic pregnancies from routine antenatal clinics. Detailed anthropometric measurements (including BMI and skinfold thickness) and fasting blood samples (for TSH, FT4, FT3, HbA1c, lipid profile, plasma glucose and insulin resistance (HOMA-IR) analysis) were obtained at 28 weeks gestation.
Results: In comparison to euthyroid women (n=741), women with isolated hypothyroxinaemia (n=82) had significantly increased BMI (29.5 vs. 27.5kg/m2, p<0.001), sum of skinfolds (57.5 vs. 51.3mm, p=0.002), fasting plasma glucose (4.5 vs. 4.3mmol/l, p=0.01), triglycerides (2.3 vs. 2.0mmol/l, p<0.001) and HOMA-IR (2.0 vs. 1.3, p=0.001). Metabolic parameters in women with subclinical hypothyroidism (n=133) were similar to those in euthyroid women. Maternal FT4 was negatively associated with: BMI (r=-0.22), HbA1c (r=-0.14), triglycerides (r=-0.17), HOMA-IR (r=-0.15) and total/HDL cholesterol ratio (r=-0.09). Maternal FT3:FT4 ratio was positively associated with BMI (r=0.4), HbA1c (r=0.21), triglycerides (r=0.2) and HOMA–IR (r=0.33). TSH was not associated with the metabolic parameters assessed.






Recently increasing numbers of studies have shown associations between mild maternal thyroid hormone insufficiency (including subclinical hypothyroidism and isolated hypothyroxinaemia) in pregnancy and impaired neuropsychological development of the offspring, as well as several obstetric complications, such as miscarriage, preterm delivery, gestational hypertension and pre-eclampsia  ADDIN EN.CITE (1-3) . Several of these studies  ADDIN EN.CITE (4-6), although not all  ADDIN EN.CITE (7,8)  have also shown that subclinical hypothyroidism in pregnancy is associated with an increased risk of gestational diabetes. Isolated hypothyroxinaemia has also been shown to be associated with gestational diabetes  ADDIN EN.CITE (7), and a recent study found that lower free thyroxine (FT4) levels and higher free triiodothyronine (FT3) to FT4 ratios (suggesting higher peripheral deiodinase activity leading to conversion of FT4 to FT3) in pregnant women are associated with several adverse metabolic parameters relating to obesity, glycaemia, insulin resistance and lipid profile  ADDIN EN.CITE (9). It is possible that these adverse metabolic parameters partly explain the poor obstetric outcomes observed in pregnant women with mild maternal thyroid insufficiency  ADDIN EN.CITE (10-12).





A total of 988 healthy non-diabetic Caucasian women with singleton pregnancies were recruited into the Exeter Family Study of Childhood Health  ADDIN EN.CITE (13). These women had detailed anthropometric measurements: height, weight, and skinfold measures (triceps, biceps, and subscapular) and fasting blood samples taken at 28 weeks gestation. After exclusion of women on thyroid related medications (levothyroxine n=18, propylthiouracil n=3) and women with overt biochemical hypothyroidism (n=10) or hyperthyroidism (n=1) on the blood samples, data from 956 women were included in this study.  
The study was approved by the North and East Devon Local Research Ethics Committee, and all participants gave informed written consent.
Analysis of thyroid function and biochemical metabolic parameters
Thyroid function tests (TSH, FT4 and FT3) and thyroid peroxidase antibodies (TPO-Ab) were measured on the stored serum samples. Serum TSH, FT4 and FT3 were analysed using the electrochemiluminescent immunoassay, run on the Modular E170 Analyzer (Roche, Burgess Hill, UK). Intra-assay coefficients of variations were: TSH <5.3%, FT4 <5.3% and FT3 <5.1%. The manufacturer’s population reference ranges were: TSH 0.35-4.5 mIU/l, FT4 11-24 pmol/l, and FT3 3.9-6.8 pmol/l. High TSH in this study of women in the third trimester was defined as >3mIU/L, the generally accepted upper limit of the reference range in the second and third trimesters in the Caucasian populations  ADDIN EN.CITE (1,2). Subclinical hypothyroidism was defined as high TSH (>3mIU/L) with FT4 within the reference range. Isolated maternal hypothyroxinaemia was defined as FT4 below the 10th centile (<10.4pmol/L) with TSH within the reference range. TPO-Abs were analysed using the competitive immunoassay (Roche, Burgess Hill, UK), and a titre above 34 IU/ml was considered positive.  
Fasting plasma glucose, serum insulin and lipid profile, and glycosylated haemoglobin (HbA1c) were analysed in the fresh blood samples, as previously described  ADDIN EN.CITE (13). We analysed homeostasis model of assessment for insulin resistance (HOMA-IR) to estimate fasting insulin sensitivity using the formula: fasting serum insulin (mIU/l) x fasting plasma glucose (mmol/l)/22.5. 
Statistical analysis





Participants had a mean (SD) age of 30.1 (5.1) years and BMI of 27.9 (4.6) kg/m2; 46% were primiparous and 14% smoked during pregnancy. 
Metabolic parameters in pregnant women with subclinical hypothyroidism and isolated hypothyroxinaemia
A total of 133 (13.9%) women in our cohort had subclinical hypothyroidism, and 82 (8.6%) had isolated hypothyroxinaemia. 
There was no difference in metabolic parameters between women with subclinical hypothyroidism and euthyroid women (Table 1). Metabolic parameters in women with subclinical hypothyroidism who had TSH greater than 5mIU/L (n=12) were also similar to those in euthyroid women (data not shown).  
When compared to euthyroid women, women with maternal isolated hypothyroxinaemia had significantly increased BMI (29.5 vs 27.5 kg/m2, p<0.001), sum of skinfolds (57.5 vs 51.3 mm, p=0.002), fasting plasma glucose (4.5 vs 4.3 mmol/l, p=0.01), triglycerides (2.3 vs 2.0 mmol/l, p<0.001) and HOMA-IR (2.0 vs 1.3, p=0.001), and borderline increased HbA1c (29.9 vs 28.7mmol/mol, p=0.05) (Table 1). 
Association between maternal thyroid hormone levels and metabolic parameters
In bivariate analyses, maternal FT4 was negatively associated with: BMI (r=-0.22, p<0.001), sum of skinfolds (r=-0.22, p<0.001), HbA1c (r=-0.14, p< 0.001), fasting plasma glucose (r=-0.13, p<0.001), triglycerides (r=-0.17, p<0.001), HOMA-IR (r=-0.15, p<0.001) and total/HDL cholesterol ratio (r=-0.09, p=0.03) (Table 2). Maternal FT3:FT4 ratio was positively associated with BMI (r=0.40), sum of skinfolds (r=0.37), HbA1c (r=0.21), fasting plasma glucose (r=0.24), triglycerides (r=0.2) and HOMA–IR (r=0.33) (p<0.001 for all). Maternal TSH in pregnancy was not correlated with any of the maternal metabolic parameters assessed. 
Women with the lowest FT4 quartile and the highest  FT3:FT4 ratio quartile had significantly higher BMI, sum of skinfolds, HbA1c, fasting plasma glucose, triglycerides and HOMA-IR as compared to women with the highest FT4 quartile and the lowest FT3:FT4 ratio quartile, respectively (p<=0.001 for all) (Table 3). There was no difference in total/HDL cholesterol ratio between groups.
In multivariable regression analyses (Table 4), FT4 was independently associated with BMI, HbA1c, triglycerides and total/HDL cholesterol ratio, but not HOMA-IR. FT3:FT4 ratio was independently associated with BMI, HbA1c and HOMA-IR but not triglycerides. 
Association between maternal TPO-Ab status and metabolic parameters




In this study of healthy non-diabetic pregnant women, we found that women with isolated hypothyroxinaemia have worse metabolic parameters with increased obesity, glycaemia, triglycerides and insulin resistance compared to euthyroid women. In contrast subclinical hypothyroidism in pregnancy was not associated with these adverse metabolic parameters.  We also identified lower maternal serum FT4 and higher FT3:FT4 ratio (indicating an increased peripheral deiodinase activity leading to conversion of FT4 to FT3) was associated with adverse metabolic parameters.  
Thyroid hormones play key roles in regulating metabolic processes and energy homeostasis in the body (14). It is well known that overt thyroid dysfunction (hypothyroidism or hyperthyroidism) affects body weight; and recent studies have shown that even small variations in thyroid hormone levels within the reference range are associated with significant metabolic consequences and changes in body weight  ADDIN EN.CITE (14,15). In the mouse model of type 2 diabetes, thyroid hormone has been shown to improve glycaemia and insulin sensitivity  ADDIN EN.CITE (16). Our finding of the inverse correlation between maternal serum FT4 and maternal BMI is consistent with previous studies in the pregnant and non-pregnant populations  ADDIN EN.CITE (17-21). In the general population, low FT4 as well as high FT3:FT4 ratio have also been shown to be associated with adverse metabolic parameters, including less favourable lipid profile, blood pressure and insulin resistance  ADDIN EN.CITE (22-26). It is thought that lower FT4 levels are compensated by a higher peripheral deiodinase activity resulting in higher conversion of FT4 to active thyroid hormone FT3 and higher FT3:FT4 ratio  ADDIN EN.CITE (18). In a recent study of 321 healthy pregnant women without a history of thyroid dysfunction, Bassols et al. found that decreasing FT4 and increasing FT3:FT4 ratios are similarly associated with less favourable metabolic profile  ADDIN EN.CITE (9). In addition to confirming the associations in a larger cohort of pregnant women, our study also demonstrates the presence of worse metabolic parameters in women with maternal hypothyroxinaemia as compared to euthyroid women. In contrast, despite several studies  ADDIN EN.CITE (4-6), but not all  ADDIN EN.CITE (7,8), showing association between subclinical hypothyroidism in pregnancy and gestational diabetes, we were unable to demonstrate that pregnant women with subclinical hypothyroidism have less favourable metabolic parameters than euthyroid pregnant women. The possible explanations for this discrepant observations include differences in study populations (for example, women with gestational diabetes were excluded in our study) and different TSH cut-off levels used to define subclinical hypothyroidism. 
As it is a cross-sectional observational study, our study cannot ascertain that the observed less favourable metabolic parameters are caused by changes in the thyroid hormone levels. Indeed, it is possible that the associations between maternal thyroid function and metabolic parameters are mediated by obesity as glycaemia, insulin resistance and dyslipidaemia are closely associated with obesity. Several lines of evidence support the hypothesis that changes in thyroid hormone levels are the consequence rather than the cause of changes in body weight. Increased subcutaneous fat has been shown to be associated with lower FT4 and higher TSH levels in euthyroid adults  ADDIN EN.CITE (27). A study in iodine deficient pregnant women showed that obesity is associated with an increased risk of maternal hypothyroxinaemia  ADDIN EN.CITE (28). It is thought that obesity stimulates peripheral deiodinase activity as an adaptation process to increase energy expenditure resulting in an increased conversion of FT4 to FT3 and high FT3:FT4 ratio (20). More importantly, weight loss following dietary and life-style interventions have been shown to be associated in changes in thyroid hormone levels, including decrease in FT3 level and FT3:FT4 ratio  ADDIN EN.CITE (29,30). Together, these observations suggest pregnant women should be encouraged to avoid excess weight gain to prevent maternal hypothyroxinaemia.
We acknowledge a number of other limitations in this study. First, we carried out thyroid function tests on stored serum samples, however it has been shown that serum TSH, FT4, FT3 and TPO-Ab concentrations remain stable after storage for several years (31). Second, women with gestational diabetes were excluded from the study during recruitment, therefore we are unable to analyse whether the observed association between isolated hypothyroxinaemia and adverse metabolic parameters extended to an increased risk of gestational diabetes.
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Table 1. Comparison of metabolic parameters between euthyroid mothers and those with subclinical hypothyroidism and euthyroid mothers and those with isolated hypothyroxinaemia in pregnancy (Data presented as Mean +/- SD or *Geometric mean (SD range))
Metabolic parameters	Euthyroid controls(n=741)	Subclinical hypothyroidism(n=133)	p-value** 	Isolated hypothyroxinaemia(n=82)	p-value** 
BMI (kg/m2)*	27.5 (23.4-32.4)	27.5 (23.7-32.1)	0.7	29.5 (25.1 -34.7)	<0.001
Sum of skinfolds (mm)*	51.3 (37.2-70.8)	50.1 (33.3-69.2)	0.9	57.5 (40.7-81.3)	0.002
HbA1c (mmol/mol)	28.7 (3.7)	28.5 (3.9)	0.7	29.9 (4.6)	0.05
Fasting plasma glucose (mmol/L)	4.3 (0.4)	4.3 (3.8)	0.8	4.5(0.4)	0.01
Triglycerides (mmol/L)*	2.0 (1.5-2.8)	2.0 (1.4-2.8)	0.7	2.3 (1.7- 3.3)	<0.001
HOMA-IR*	1.3 (0.7-2.0)	1.0 (0.8-2.0)	0.4	2.0 (0.9-2.8)	0.001












**p-values refer to euthyroid controls vs. subclinical hypothyroidism and euthyroid controls vs. isolated hypothyroxinaemia


Table 2. Correlations between maternal TSH, FT4, FT3:FT4 ratio and metabolic parameters at 28 weeks gestation 

Metabolic parameters	TSH*r (p-value)	FT4r (p-value)	FT3:FT4 ratior (p-value)
BMI (kg/m2)*	0.007 (0.8)	-0.22 (<0.001)	0.40 (<0.001)
Sum of skinfolds (mm)*	0.013 (0.7)	-0.22 (<0.001)	0.37 (<0.001)
HbA1c (mmol/mol)	.0.007 (0.8)	-0.14 (<0.001)	0.21 (<0.001)
Fasting plasma glucose (mmol/l)	-0.01 (0.8)	-0.13 (<0.001)	0.24 (<0.001)
Triglycerides (mmol/l)*	0.006 (0.9)	-0.17 (<0.001)	0.20 (<0.001)
HOMA–IR*	0.02 ( 0.5)	-0.15 (<0.001)	0.33 (<0.001)












Table 3. Correlations between upper and lower FT4 and FT3:FT4 ratio quartiles, and maternal metabolic parameters 
(Data presented as Mean +/- SD or *Geometric mean (SD range))
Metabolic parameters	FT4Lower quartile	FT4Upper Quartile	p-value	FT3:FT4 ratioLower quartile	FT3:FT4 ratioUpper Quartile	p-value
BMI (kg/m2)*	28.8 (24.6-33.9)	26.9 (22.9-31.6)	<0.001	25.1 (21.9-28.8)	30.2 (26.7-35.5)	<0.001
Sum of skinfolds (mm)*	57.4 (41.7-79.4)	47.9 (34.7-66.1)	<0.001	44.7 (32.4-61.7)	63.1 (45.7-87.1)	<0.001
HbA1c (mmol/mol)	29.5 (4.1)	28.1 (3.8)	0.001	28.0 (3.7)	29.9 (4.4)	<0.001
Fasting plasma glucose (mmol/L)	4.4 (0.4)	4.3 (0.4)	<0.001	4.2 (0.3)	4.5 (0.4)	<0.001
Triglyceride (mmol/L)*	2.2 (1.6-3.1)	1.9 (1.4-2.5)	<0.001	1.9 (1.4-2.6)	2.2 (1.6-3.1)	<0.001
HOMA-IR*	2.0 (1.0 – 2.6)	1.0 (0.8-2.0)	<0.001	1.0 (0.6-1.6)	2.0 (1.0-2.5)	<0.001














Table 4. Multivariable regression analysis to demonstrate the relationships between maternal FT4 and FT3:FT4 ratio with metabolic parameters. Partial R is the adjusted correlation coefficient. *Denotes variable transformed using natural logs (allowing β coefficients to be interpreted in terms of percentage change)






Total/HDL Cholesterol	0.14	0.34	0.13, 0.54 	3.25	0.001
Maternal FT3:FT4 ratio
BMI (kg/m2)*	0.27	0.100	0.075, 0.126	7.62	<0.001
HbA1c (mmol/mol)	0.11	0.001	0.000, 0.002	2.98	0.003
Triglycerides (mmol/l)*	0.05	0.008	-0.003, 0.018	1.45	0.15
HOMA-IR*	0.13	0.014	0.006, 0.022	3.45	0.001











18



